ORN Webinar Fall 2021 #3 - COVID 19 Changes to Methadone Treatment at One Clinic in Central Pennsylvania-Event Recording

Video Transcription

Video Summary

The video discussed changes to methadone treatment at an opioid treatment program in Central Pennsylvania during the COVID-19 pandemic. Dr. Sarah Kawasaki, MD, presented the information and discussed the history of methadone treatment in the country, including the regulations and stigma associated with it. She also discussed the impact of COVID-19 on the clinic's policies and the outcomes for patients during that time. The clinic made changes to its take-home medication policies to reduce exposure to COVID-19, and this resulted in a significant decrease in attrition rates. However, the state of Pennsylvania plans to return to pre-pandemic regulations, which has led to disappointment among patients and providers. Dr. Kawasaki discussed the need for new legislation to improve the regulations and reduce stigma surrounding opioid treatment programs. The video also addressed questions about the use of THC for patients, telehealth services during the pandemic, and the handling of UDS with telehealth. Additionally, the dosage ranges for methadone maintenance were discussed, as well as the policy for patients who are non-compliant. The video concluded with a discussion on the future advocacy for better regulations and outcomes in opioid treatment programs.

Keywords

methadone treatment

opioid treatment program

COVID-19 pandemic

regulations

stigma

take-home medication policies

attrition rates

legislation

telehealth services